GT BIOPHARMA INC

GTBPNASDAQ

🏆 #3754 by market capEarnings Aug 12US Equity

$990.00▲ $68.21 (+6.89%)

Simulated price

1h—

24h▲ 6.9%

7d—

14d—

30d—

1y—

🏦Market Cap

$14M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

36.5%

Healthy

💵FCF Margin

17.5%

Healthy

⚖️P/S Ratio

225.6x

Expensive

Otter Score

63

Fair

Earnings

Q2 · 2026Reported 2026-05-15

Earnings Per Share

Actual

-0.11

Expected

-0.08

miss

−37.50%

YoY +85.50%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

-0.11

miss

Q1 2026

-2.22

miss

Q4 2025

-0.83

miss

Q3 2025

-0.55

beat